![](https://www.lachmanconsultants.com/wp-content/uploads/2015/07/blog-image-2.png)
The Backlog at OGD – a Historical Look
Yesterday, a reporter asked me how long has there been a backlog at the Office of Generic Drugs (OGD). I told the reporter that the nature of the ANDA review and approval process will guarantee that there is always a backlog. That is because firms submit applications on an ongoing basis, and it takes the […]